RestoreX improves erectile function outcomes after prostate surgery

This study investigated the effectiveness of RestoreX penile traction device in the treatment of penile complications after prostate surgery. Researchers suggested that RestoreX improves penis length and sexual function after prostate surgery. 

Prostate surgery can impact male sexual function. The effects can go from reductions in penis length, erectile dysfunction, an increased risk for Peyronie's disease, among others. These disorders greatly affect the sexual ability of men, decreasing their quality of life and of their partners.   

Penile treatment is associated with various therapies such as drugs, penis injections, and/or vacuum erection devices. However, these are only of limited effectiveness. 

Penile traction therapy is another therapy commonly used to improve penile curve and length. It consists of wearing a penile traction device for a set amount of time each day. The device stretches the penis straight out, or in the direction that's opposite of the curve. It has shown very good results in patients with Peyronie's disease. This condition is associated with a curved penis and erectile dysfunction.

RestoreX is a penile traction device that only requires 30 minutes of daily use. Prior studies suggested that RestoreX improves erectile function. However, the effectiveness of traction therapy in men with penile complications after prostate surgery is still not clear.

This study included information about 55 men who had prostate surgery. Patients were assigned to receive traction therapy (group 1; 30), or no treatment (25). Patients from group 1 received therapy either one time a day for 5 days (A) or 2 times a day for 7 days (B). Participants were treated with one of two penile therapy methods for 6 months, followed by a 3-month follow-up period. The main outcome measured the changes in penile length, erectile function, side effects, and satisfaction.

At 6 months, group 1 achieved a greater improvement of penile length, erectile function, and sexual satisfaction compared to group 2.

The use of other erectile therapies such as penis injections was lower in group 1 (19%) when compared to group 2 (50%). The use of medications to achieve an erection was also lower in group 1 (86%) when compared to group 2 (94%). More men in group 1 reported improvement in penile length when compared to group 2.

Negative side effects were mild. 87% of patients reported they would repeat therapy and 93% would recommend it to others.

This study concluded that RestoreX treatment improves penile outcomes in men who underwent prostate surgery. 

This study had a very small number of participants. Larger studies are needed.